Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

bFGF and tumor angiogenesis — Back in the limelight?

Nature Medicine volume 3, pages 1083–1084 (1997)Cite this article

An FGF-binding protein secreted by tumor cells suggests how bFGF may stimulate tumor angiogenesis (pages 1137–1140).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).

    Article  CAS  PubMed  Google Scholar 

  2. Kerbel, R.S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents. BioEssays 13, 31–36 (1991).

    Article  CAS  PubMed  Google Scholar 

  3. Czubayko, F. et al. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Med. 3, 1137–1140 (1997).

    Article  CAS  PubMed  Google Scholar 

  4. Risau, W. What, if anything, is an angiogenic factor?. Cancer Metastasis Rev. 15, 149–151 (1996).

    Article  CAS  PubMed  Google Scholar 

  5. Wu, D.Q. et al. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 266, 16778–16785 (1991).

    CAS  PubMed  Google Scholar 

  6. Czubayko, F., Smith, R.V., Chung, H.C. & Wellstein, A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem. 269, 28243–28248 (1994).

    CAS  PubMed  Google Scholar 

  7. Friesel, R.E. & Maciag, T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9, 919–925 (1995).

    Article  CAS  PubMed  Google Scholar 

  8. Kandel, J. et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095–1104 (1991).

    Article  CAS  PubMed  Google Scholar 

  9. Cheng, S.Y. et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. U.S.A. 93, 8502–8507 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rak, J. et al. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev. 14, 263–277 (1995).

    Article  CAS  PubMed  Google Scholar 

  11. Bouck, N., Stellmach, V. & Hsu, S.C. How tumors become angiogenic. Adv. Cancer Res. 69, 135–174 (1996).

    Article  CAS  PubMed  Google Scholar 

  12. Stavri, G.T. et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle Cells. Circulation 92, 11–14 (1995).

    Article  CAS  PubMed  Google Scholar 

  13. Goto, F., Goto, K. & Folkman, J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial Cells within collagen gels. Lab. Invest. 69, 508–517 (1993).

    CAS  PubMed  Google Scholar 

  14. Asahara, T. et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, 365–371 (1995).

    Article  CAS  Google Scholar 

  15. Millauer, B. et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615–1620 (1996).

    CAS  PubMed  Google Scholar 

  16. Warren, R.S. et al. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789–1797 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Yuan, F. et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. U.S.A. 93, 14765–14770 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Program, Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, M4N 3M5, Canada

    Janusz Rak & Robert S. Kerbel

Authors
  1. Janusz Rak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert S. Kerbel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rak, J., Kerbel, R. bFGF and tumor angiogenesis — Back in the limelight?. Nat Med 3, 1083–1084 (1997). https://doi.org/10.1038/nm1097-1083

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1097-1083

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing